Immunogenicity and Safety of One versus Two Doses of Quadrivalent Meningococcal Conjugate Vaccine in Youth Infected with HIV

OBJECTIVE: To compare the immunogenicity of one vs. two doses of meningococcal conjugate vaccine (MCV4) in youth infected with HIV. STUDY DESIGN: P1065 was a Phase I/II immunogenicity and safety trial of MCV4 in 324 youth infected with HIV performed at 27 sites of the IMPAACT network in the U.S. At...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lujan-Zilbermann, Jorge, Warshaw, Meredith G., Williams, Paige L., Spector, Stephen A., Decker, Michael D., Abzug, Mark J., Heckman, Barb, Manzella, Adam, Kabat, Bill, Jean-Philippe, Patrick, Nachman, Sharon, Siberry, George K
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434315/
https://ncbi.nlm.nih.gov/pubmed/22622049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2012.04.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados